Diverticulitis Disease Markets And Competition Analysis Report Featuring 48 Companies - Forecast To 2030

(MENAFN- GlobeNewsWire - Nasdaq) The diverticulitis market is growing due to rising cases linked to aging and lifestyle factors, especially in urban areas. Key opportunities lie in advancing diagnostic technologies and diverse treatment options, including non-invasive approaches. Major demand is in North America, Europe, and rapidly developing Asia-Pacific regions.

Dublin, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The "Diverticulitis Disease - Global Strategic Business Report" has been added to ResearchAndMarkets's offering.
The global market for Diverticulitis Disease was estimated at US$1.8 Billion in 2024 and is projected to reach US$2.6 Billion by 2030, growing at a CAGR of 6.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Diverticulitis Disease market.

The growth in the diverticulitis disease market is driven by several factors, including the rising prevalence of gastrointestinal disorders associated with aging populations and dietary changes, particularly in urbanized areas. Advances in diagnostic imaging technologies and increased access to colonoscopy screenings are enabling earlier and more accurate diagnoses, expanding the base of treated patients. Changes in clinical guidelines emphasizing conservative management have increased the role of pharmaceuticals, creating opportunities for drug manufacturers.

Simultaneously, the expansion of minimally invasive surgical techniques has boosted the demand for surgical instruments and robotic systems. Growing patient awareness, combined with greater health literacy and demand for outpatient care, is reshaping the way diverticulitis is managed across healthcare settings.

The development of new pharmaceutical agents targeting inflammation and gut microbiota modulation is also fueling innovation in the treatment pipeline. Moreover, the integration of gastrointestinal care into broader chronic disease management frameworks is reinforcing its strategic importance within global healthcare systems.
Key Insights:

• Market Growth: Understand the significant growth trajectory of the Medications Treatment segment, which is expected to reach US$666.1 Million by 2030 with a CAGR of a 5.8%. The Surgery Treatment segment is also set to grow at 5.5% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $489.1 Million in 2024, and China, forecasted to grow at an impressive 10.3% CAGR to reach $542.3 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Diverticulitis Disease Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Diverticulitis Disease Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Diverticulitis Disease Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Laboratories, Allergan (AbbVie), AstraZeneca, Bausch Health Companies, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 48 companies featured in this Diverticulitis Disease market report include:

• Abbott Laboratories
• Allergan (AbbVie)
• AstraZeneca
• Bausch Health Companies
• Baxter International
• Bristol-Myers Squibb
• Ferring Pharmaceuticals
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Medtronic
• Mylan (Viatris)
• Novartis
• Pfizer
• Roche
• Sanofi
• Sandoz (Novartis)
• Takeda Pharmaceutical
• Teva Pharmaceutical
• UCB

This edition integrates the latest global trade and economic shifts into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.

Key Attributes

Report Attribute	Details
No. of Pages	294
Forecast Period	2024-2030
Estimated Market Value (USD) in 2024	$1.8 Billion
Forecasted Market Value (USD) by 2030	$2.6 Billion
Compound Annual Growth Rate	6.7%
Regions Covered	Global

MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Tariff Impact on Global Supply Chain Patterns
• Diverticulitis Disease - Global Key Competitors Percentage Market Share in 2025 (E)
• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)

MARKET TRENDS & DRIVERS

• Rising Prevalence of Digestive Disorders Drives Market for Diverticulitis Treatment
• Aging Global Population Spurs Growth in Diverticulitis Diagnoses and Therapies
• Increasing Use of Minimally Invasive Surgical Techniques Strengthens Treatment Options
• Advances in Imaging and Diagnostic Tools Propel Early Detection Rates
• Growing Awareness Campaigns Highlight Disease Management and Drive Patient Volumes
• Lifestyle Changes and Poor Dietary Habits Sustain Disease Incidence
• High Demand for Personalized Medicine Expands Market for Targeted Therapies
• Availability of Advanced Antibiotics Enhances Recovery Outcomes and Drives Adoption
• Integration of AI and Predictive Analytics in Diagnostics Generates Growth Potential
• Increased Healthcare Spending in Developing Regions Expands Access to Treatment
• Innovation in Biologic and Anti-Inflammatory Drugs Strengthens Pipeline Prospects
• Recurrence Prevention Strategies Drive Demand for Long-Term Management Therapies

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Diverticulitis Disease Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN15092025004107003653ID1110061742